Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers

Sci Rep. 2023 Feb 2;13(1):1906. doi: 10.1038/s41598-023-28884-7.

Aya Sugiyama¹, Akemi Kurisu¹, Shintaro Nagashima¹, Kiyomi Hando¹, Khilola Saipova^{1

2}, Sayyora Akhmedova^{1

3}, Kanon Abe¹, Hirohito Imada¹, Md Razeen Ashraf Hussain¹, Serge Ouoba^{1

4}, Bunthen E^{1

5}, Ko Ko¹, Tomoyuki Akita¹, Shinichi Yamazaki⁶, Michiya Yokozaki⁶, Junko Tanaka⁷

¹ Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
² Department of Clinical Radiology and Oncology, Andijan State Medical Institute, Andijan, Uzbekistan.
³ Department of Cardiorheumatology, Republican Specialized Scientific-Practical Medical Center of Pediatrics, Tashkent, Uzbekistan.
⁴ Unité de Recherche Clinique de Nanoro (URCN), Institut de Recherche en Science de La Santé (IRSS), Nanoro, Burkina Faso.
⁵ Payment Certification Agency (PCA), Ministry of Health, Phnom Penh, Cambodia.
⁶ Division of Clinical Laboratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
⁷ Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. jun-tanaka@hiroshima-u.ac.jp.

No abstract available

Publication types